Zhangwang Li

549 total citations
20 papers, 380 citations indexed

About

Zhangwang Li is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Zhangwang Li has authored 20 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Zhangwang Li's work include Inflammasome and immune disorders (5 papers), Cancer-related molecular mechanisms research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Zhangwang Li is often cited by papers focused on Inflammasome and immune disorders (5 papers), Cancer-related molecular mechanisms research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Zhangwang Li collaborates with scholars based in China, United States and Hong Kong. Zhangwang Li's co-authors include Panpan Xia, Ao Shi, Peng Yu, Jiahui He, Jing Zhang, Xiaoyi Tang, Peng Yu, Deju Zhang, Peng Yu and Minxuan Xu and has published in prestigious journals such as Carbohydrate Polymers, Frontiers in Immunology and Journal of Cellular Physiology.

In The Last Decade

Zhangwang Li

20 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhangwang Li China 10 174 109 78 52 48 20 380
Chen‐Pang Hou Taiwan 13 130 0.7× 156 1.4× 55 0.7× 30 0.6× 63 1.3× 58 404
Xiaoqin Luo China 10 189 1.1× 68 0.6× 62 0.8× 50 1.0× 33 0.7× 20 415
Weirong Hu China 11 156 0.9× 65 0.6× 58 0.7× 34 0.7× 26 0.5× 26 317
Jingchao Liu China 11 152 0.9× 104 1.0× 70 0.9× 75 1.4× 35 0.7× 44 396
Xiaodan Zhu China 13 152 0.9× 147 1.3× 34 0.4× 57 1.1× 60 1.3× 37 407
Tianyu Yu China 13 170 1.0× 59 0.5× 45 0.6× 47 0.9× 70 1.5× 31 490
Zhining Liu China 11 164 0.9× 38 0.3× 89 1.1× 59 1.1× 54 1.1× 28 386
Rui Ke China 12 198 1.1× 120 1.1× 61 0.8× 45 0.9× 30 0.6× 25 409
Chunmei Xu China 12 151 0.9× 58 0.5× 66 0.8× 41 0.8× 57 1.2× 35 384

Countries citing papers authored by Zhangwang Li

Since Specialization
Citations

This map shows the geographic impact of Zhangwang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangwang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangwang Li more than expected).

Fields of papers citing papers by Zhangwang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhangwang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangwang Li. The network helps show where Zhangwang Li may publish in the future.

Co-authorship network of co-authors of Zhangwang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhangwang Li. A scholar is included among the top collaborators of Zhangwang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhangwang Li. Zhangwang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Xinxin, Zhangwang Li, Liping Yan, et al.. (2025). Integrative analysis of T cell-mediated tumor killing-related genes reveals KIF11 as a novel therapeutic target in esophageal squamous cell carcinoma. Journal of Translational Medicine. 23(1). 197–197. 2 indexed citations
2.
Ye, Zhenfeng, Jing Zhang, Zhou Xu, et al.. (2024). Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome. Human Cell. 37(4). 959–971. 7 indexed citations
3.
Luo, Wei, Jing Zhang, Zhangwang Li, et al.. (2023). Polysaccharides-based nanocarriers enhance the anti-inflammatory effect of curcumin. Carbohydrate Polymers. 311. 120718–120718. 48 indexed citations
4.
Li, Zhangwang, Jiashu Han, Wenqing Liu, et al.. (2023). Multifaceted roles of T cells in obesity and obesity‐related complications: A narrative review. Obesity Reviews. 24(11). e13621–e13621. 2 indexed citations
5.
Li, Chun‐Xiu, Deju Zhang, Zhangwang Li, et al.. (2022). Advances in T Cells Based on Inflammation in Metabolic Diseases. Cells. 11(22). 3554–3554. 23 indexed citations
6.
Zhang, Jing, Hongguang Sheng, Xiaoyi Tang, et al.. (2022). Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19. Frontiers in Cellular and Infection Microbiology. 12. 935280–935280. 2 indexed citations
7.
Zhou, Yiwen, Zhangwang Li, Panpan Xia, et al.. (2022). Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases. Frontiers in Cardiovascular Medicine. 9. 909716–909716. 9 indexed citations
8.
Zhang, Yize, Ying Deng, Cong Wang, et al.. (2022). Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes. BMC Medical Genomics. 15(1). 166–166. 6 indexed citations
9.
Chen, Xinyue, Zhangwang Li, Jiashu Han, et al.. (2022). Advances in the study of RNA-binding proteins in diabetic complications. Molecular Metabolism. 62. 101515–101515. 16 indexed citations
10.
Zhang, Jing, Fuwei Liu, Zhangwang Li, et al.. (2022). Liver Fibrosis Scores and Clinical Outcomes in Patients With COVID-19. Frontiers in Medicine. 9. 829423–829423. 12 indexed citations
11.
Li, Zhangwang, et al.. (2022). Exosomes Regulate NLRP3 Inflammasome in Diseases. Frontiers in Cell and Developmental Biology. 9. 802509–802509. 22 indexed citations
12.
Xu, Jiawei, Deju Zhang, WU Shu-qin, et al.. (2022). MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring. Frontiers in Immunology. 13. 1016575–1016575. 18 indexed citations
13.
Li, Zhangwang, Minxuan Xu, Deju Zhang, et al.. (2022). O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease. Cells. 11(22). 3637–3637. 8 indexed citations
14.
Wang, Yongbo, Xingyu Liu, Panpan Xia, et al.. (2022). The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases. Frontiers in Immunology. 13. 901166–901166. 5 indexed citations
15.
He, Jiahui, Zhangwang Li, Panpan Xia, et al.. (2022). Ferroptosis and ferritinophagy in diabetes complications. Molecular Metabolism. 60. 101470–101470. 118 indexed citations
16.
Yu, Peng, Ziqi Tan, Zhangwang Li, et al.. (2022). Obesity and clinical outcomes in COVID-19 patients without comorbidities, a post-hoc analysis from ORCHID trial. Frontiers in Endocrinology. 13. 936976–936976. 2 indexed citations
17.
Zhang, Deju, Ziyan Hu, Jing Zhang, et al.. (2022). Research progress on ncRNAs regulation of mitochondrial dynamics in diabetes. Journal of Cellular Physiology. 237(11). 4112–4131. 5 indexed citations
18.
19.
Chen, Xinyue, Xingyu Liu, Zhangwang Li, et al.. (2022). AMPK: The key to ischemia‐reperfusion injury. Journal of Cellular Physiology. 237(11). 4079–4096. 55 indexed citations
20.
Xia, Zhilin, et al.. (2009). Thin films' thickness uniformity associated with the method of electron beam evaporation. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7516. 75160V–75160V. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026